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Regulation of Lifespan in Drosophila
by Modulation of Genes
in the TOR Signaling Pathway
genes of the same pathway, daf-2 (insulin receptor) and
age-1 (Phosphatidyl inositol-3 kinase), lead to a dou-
bling of lifespan, and render the animals more sensitive
to dauer formation [10]. Both the dauer-formation and
lifespan-extension phenotypes are suppressed by mu-
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Pasadena, California 91125 tations in daf-16, a forkhead family transcription factor
[10, 11]. Drosophila mutations in Inr (insulin-like recep-
tor) and chico (insulin-receptor substrate), both com-
ponents of the insulin-signaling pathway, also regulateSummary
lifespan [12, 13]. A reduction of nutrients in the fly diet
has been shown to extend lifespan in the fly [14–16].In many species, reducing nutrient intake without
Reduced availability of protein or yeast in the fly dietcausing malnutrition extends lifespan [1–3]. Like DR
can reduce signaling through the InR/PI3K pathway, as(dietary restriction), modulation of genes in the insulin-
measured by using a pleckstrin homology domain greensignaling pathway, known to alter nutrient sensing,
fluorescent protein (PH-GFP), which is localized to thehas been shown to extend lifespan in various species
cell membrane when the PI3K pathway is active [17].[1–4]. In Drosophila, the target of rapamycin (TOR) and
Furthermore, the lifespan extension that is observed bythe insulin pathways have emerged as major regula-
chico mutant flies is dependent on the nutritional con-tors of growth and size. Hence we examined the role
tent of fly food, suggesting an overlap between the twoof TOR pathway genes in regulating lifespan by using
mechanisms of lifespan extension [14].Drosophila. We show that inhibition of TOR signaling
In Drosophila, nutrient availability and insulin signalingpathway by alteration of the expression of genes in this
have been shown to be critical factors in regulating notnutrient-sensing pathway, which is conserved from
only lifespan but also growth and size [18]. Inhibition ofyeast to human, extends lifespan in a manner that
InR/PI3K signaling, by using mutations in the pathway,may overlap with known effects of dietary restriction
phenocopies the cellular and organismal effects of star-on longevity. In Drosophila, TSC1 and TSC2 (tuberous
vation, leading to a reduction in the size of the fly [17,sclerosis complex genes 1 and 2) act together to inhibit
19, 20]. Tsc1, Tsc2, TOR, and S6 kinase have emergedTOR (target of rapamycin), which mediates a signaling
as important regulators of growth and size in Drosophilapathway that couples amino acid availability to S6 ki-
in a pathway that is parallel to, but also interactive with,nase, translation initiation, and growth [5]. We find that
the insulin pathway (Figure S1) [21]. Recent evidenceoverexpression of dTsc1, dTsc2, or dominant-negative
suggests that the fat body in Drosophila acts as a nutri-forms of dTOR or dS6K all cause lifespan extension.
ent sensor, which uses TOR signaling to generate aModulation of expression in the fat is sufficient for
humoral signal that modulates insulin signaling andthe lifespan-extension effects. The lifespan extensions
growth in peripheral tissues [22]. TOR deficiency in theare dependent on nutritional condition, suggesting a
nematode C. elegans was recently shown to extendpossible link between the TOR pathway and dietary
lifespan [23]. We therefore tested whether modulatingrestriction.
the activities of genes in the TOR pathway might regulate
lifespan.
Introduction
A reduction in nutrient intake, also known as dietary Results and Discussion
restriction (DR), extends lifespan in various species in-
cluding worm (C. elegans), fly (D. melanogaster), yeast The Drosophila homologs of human Tsc1 (Hamartin) and
(S. cerevisiae), and mouse (Mus musculus) [1, 2]. Like Tsc2 (tuberin) function in vivo as a complex that controls
DR, modulation of genes in the insulin-signaling path- growth and size in a cell-autonomous manner [24–27].
way, known to alter nutrient sensing, has been shown To examine their role in regulating lifespan, we overex-
to extend lifespan in various species [1–4]. Evolutionary pressed dTsc1 and dTsc2 by using constructs provided
theory suggests that DR regulates certain genetic path- by the Duojia Pan lab [5] through the ubiquitously ex-
ways that shift an organism’s metabolic investment from pressed driver, daughterless (da)-GAL4. We found that
reproduction and growth toward somatic maintenance overexpression in transgenic flies carrying UAS con-
[3, 6, 7], allowing the organism to survive under harsh structs containing dTsc1 or dTsc2 extended mean life-
environments until there are suitable reproductive con- span at 29C by 14% and 12%, respectively (Figures
ditions. In C. elegans, in response to crowding and star- 1A and 1B). Since GAL4 enhancer traps generally yield
vation, the insulin/insulin-like growth factor (IGF-1) sig- stronger effects at 29C, we chose to perform most of
naling pathway controls the formation of the dauer larva, the experiments at that temperature [28].
an alternative developmental state that is nonreproduc- dTsc1 and dTsc2 physically interact with dTOR [5],
ing, stress resistant, and long lived [8, 9]. Mutations in which is conserved from yeast to human as a nutrient
sensor [18]. Loss of dTsc1 in Drosophila eye leads to
an increase in cell size, provided that dTOR is present*Correspondence: benzer@caltech.edu
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Figure 1. Regulation of Lifespan by Modulating Genes in the TOR Signaling Pathway
Survival curves on standard laboratory food for male flies obtained after crossing the ubiquitously expressed da-GAL4 enhancer trap with
various UAS constructs carrying genes in the TOR signaling pathway ([A]–[E] at 29C, [F] and [G] at 25C). All logrank test p values are based
on comparison of the overexpressor strain with the driver alone. The plus symbol indicates the parental strain w1118. The mean lifespan (days)
of the various genotypes were as follows. (A) da-GAL4/UAS-dTsc1 (closed squares), 29 days (n136);/da-GAL4 (driver alone) (open triangles),
26 days (n  92); /UAS-dTsc1 (open circles), 25 days (n  109) (p  0.0001). (B) da-GAL4/UAS-dTsc2 (closed squares), 29 days (n  112);
/da-GAL4 (open triangles), 26 days (n  92); /UAS-dTsc2 (open circles), 25 days (n  118) (p  0.0001). (C) da-GAL4/UAS-dTORFRB (closed
squares), 30 days (n  126); /da-GAL4 (open triangles), 26 days (n  92); /UAS-dTORFRB (open circles), 22 days (n  98) (p  0.0001). (D)
da-GAL4/UAS-dS6kKQ (closed squares), 30 days (n  122); /da-GAL4 (open triangles), 26 days (n  92); /UAS-dS6kKQ (open circles), 23
days (n  115) (p  0.0001). (E) da-GAL4/UAS-dS6kSTDETE (closed squares), 16 days (n  75); /da-GAL4 (open triangles), 26 days (n  92);
/UAS-dS6kSTDETE (open circles), 24 days (n  40) (p  0.0001). (F) da-GAL4/UAS-dTsc2 (closed squares), 69 days (n  134); /da-GAL4 (open
triangles), 58 days (n  133); /UAS-dTsc2 (open circles), 56 days (n  126) (p  0.0001). (G) da-GAL4/UAS-dTORFRB (closed squares), 72
days (n  112); /da-GAL4 (open triangles), 58 days (n  133); /UAS-dTORFRB (open circles), 55 days (n  128) (p  0.0001).
[5]. Surprisingly, however, dTOR overexpression causes binding domain, which has been shown to prevent S
phase entry when injected into human osteosarcomaa reduction in cell size, a phenotype similar to dTOR
loss-of-function mutations, perhaps due to titration of cells [30]. The third carries TED (toxic effector domain),
containing the 754 amino acid central region, which in-cofactors required for TOR signaling [29]. We examined
the effect of dTOR on lifespan by using three UAS con- hibits cell growth and arrests cells in G1 when overex-
pressed in yeast [29]. Ubiquitous overexpression withstructs generously provided by the Thomas Neufeld lab
[29]. One carries the full-length wild-type TOR gene. the da-GAL4 driver of UAS-dTORFRB led to a mean life-
span increase at 29C of 24% (Figure 1C). However,The second carries FRB, the 11 kDa FKBP12-rapamycin
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overexpression of UAS -dTORWT or UAS-dTORTED pre- pathway is a critical mediator of nutrient signaling, we
asked whether the observed lifespan-extension effectsvented eclosion to adulthood (data not shown).
S6 kinase activation upon phosphorylation has been are dependent on nutrient conditions. We tested this
with overexpression of dTsc2 by using the ubiquitouslyimplicated in mediating the downstream effects of TOR
on translation initiation in flies and mammals [21]. S6 expressing da-GAL4 driver. Flies were allowed to devel-
op to adulthood under standard laboratory food andkinase phosphorylation of ribosomal protein S6 is ac-
companied by upregulation of a class of mRNAs con- then maintained on specially prepared food containing
various concentrations of yeast extract. At high concen-taining an oligopyrimidine tract at their transcriptional
start site termed 5TOP [31]. Some 200 genes, most of trations of yeast extract, which may be regarded as the
opposite of dietary restriction, the lifespan of controlwhich encode components of the translational appara-
tus including ribosomal proteins and elongation factors, flies (da-GAL4/) was severely reduced (Figure 3). How-
ever, overexpression of dTsc2 protects the fly from thehave this sequence and can account for about 20%
of total cellular mRNA [31]. Flies carrying homozygous deleterious effects of rich food, as if mimicking the effect
of dietary restriction (Figure 3). Similar results were ob-mutations in dS6K show a developmental delay and a
reduction in body size [32]. The stimulation of dS6K served by overexpression of the dominant-negative
form of S6 kinase (data not shown).phosphorylation by dTOR is abrogated when dTsc1 and
dTsc2 are overexpressed [5]. Furthermore, flies with re- Recent evidence from Drosophila suggests that sig-
naling through TSC is both parallel to and interactingduced dTSC1 show increased dS6 kinase activation,
and genetic reduction of S6 kinase level can rescue the with the insulin pathway [21, 25]. This is supported by
the finding that heterozygosity of dTsc1 or dTsc2 islethality caused by loss of function of dTsc1 [33].
We examined the role of S6 kinase in regulating life- sufficient to rescue the lethality of loss-of-function dInR
mutants [25]. However, the finding that loss-of-functionspan by using dominant-negative and constitutively ac-
tive constructs generously provided by the Mary Stewart mutations of dTsc1 and dPTEN, a phosphatase that nega-
tively regulates the insulin-signaling pathway, cause celllab [34]. The dominant-negative effect was achieved by
replacing the conserved lysine in the ATP binding site autonomous and additive increases in cell size suggests
that they may be in parallel pathways [25]. Furthermore,by glutamine (UAS-dS6KKQ), which causes cell-size re-
duction. The constitutively active form was generated in Drosophila, dPTEN loss of function, which leads to
an increase in cell size, is only slightly suppressible byby replacing the phosphorylation sites of S6 kinase by
acidic amino acids (UAS-dS6KSTDETE), causing an autono- loss of function of dFOXO, a fly homolog of C. elegans
daf-16 [35]. However, the increase in cell size resultingmous cell size increase [34]. By using da-GAL4 to drive
ubiquitous overexpression of the dominant-negative from dTsc1 is enhanced by dFOXO loss of function [35].
Interestingly, unlike long-lived daf-2 mutants, the life-form, we observed a mean lifespan increase of 22%
at 29C (Figure 1D). Conversely, overexpression of the span extension due to TOR deficiency in C. elegans is
not suppressible by a daf-16 mutation [23]. However,constutively active form of S6 kinase caused a mean
lifespan decrease of 34% at 29C (Figure 1E). Overex- the TOR mutant animals do not further extend lifespan
in a daf-2 background, leading to the possibility thatpression of dTsc2 and dTORFRB was also tested at 25C
and led to a 20% and 26% increase in mean lifespan TOR may be acting downstream or separately from daf-
16 to exert its lifespan effects [23].increase, respectively (Figures 1F and 1G).
To determine which tissues are responsible for the Lifespan extension has been linked with other pheno-
types, including stress resistance, metabolic rate, lipidlifespan extension, we employed various GAL4 drivers
with specific GAL4 expression pattern (Figure S2) to level, reproductive capacity, and body size [16, 36, 37].
We compared the long-lived strains described aboveoverexpress dTsc2 via a UAS promoter. Overexpression
in the eye by using the driver gmr-GAL4 or in the nervous with their respective controls for resistance to starvation
but found no significant differences (Table S1). Similarly,system by using appl-GAL4 did not extend lifespan (Fig-
ures 2A and 2B). On the other hand, by using the drivers no significant differences were observed for weight and
lipid content among these strains (Table S1). It may24B-GAL4 and PO188-GAL4, enhancer traps that are
predominantly expressed in the muscle and fat resulted be that lifespan extension can be produced by mild
modulation of these genes, whereas effects on otherin mean lifespan extensions of 27% and 37%, respec-
tively, at 29C (Figures 2C and 2D). The fat-specific driv- phenotypes require severe perturbations. While lifespan
extension is observed by using the da-GAL4 driver toers DJ634-GAL4 and PO163-GAL4, when used to over-
express dTsc2, also led to a mean lifespan extension overexpress dTsc1 or dTsc2 alone, simultaneous over-
expression of dTsc1 and dTsc2 prevented eclosion toof 22% and 31%, respectively, at 29C (Figures 2E and
2F). Using DJ634-GAL4 to overexpress the dominant- adulthood (data not shown). Similarly, no change in size
is observed if dTsc1 or dTsc2 alone are overexpressednegative form of TOR (UAS-dTORFRB) or of S6 kinase
(UAS-UAS-dS6KKQ) also led to mean lifespan increases in the eye, but a cell-autonomous decrease in size is
seen when both are overexpressed simultaneouslyof 30% and 29%, respectively, at 29C (Figures 2G and
2H). These results indicate that manipulation of the TSC, [25, 26]. Lifespan extension by chico is semidominant,
but its effect on body size is recessive [13]. DominantTOR, and S6 kinase genes in the fat tissue is sufficient
for their lifespan extension effects in Drosophila. effects on lifespan are observed with the genes Inr, EcR,
Indy, and Rpd3, but their effects on lifespan can beAmino acids have been shown to activate dS6k via
TOR, an effect that can be abrogated in the presence uncoupled from other phenotypes such as fecundity,
stress resistance, or lipid accumulation.of increased levels of dTsc1 and dTsc2 [5]. As nutrients
in the diet can modulate lifespan and because the TOR In humans, mutations in TSC1 and TSC2 lead to tuber-
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Figure 2. Dependence of Lifespan Extension on Overexpression in Specific Tissues
Survival curves, on standard laboratory food, for male flies obtained by crossing various genes in the TOR pathway by using different tissue
specific drivers along with appropriate control strains. gmr-GAL4 is expressed in the eye, appl-GAL4 in the nervous system, 24B-GAL4 and
PO188-GAL4 in the muscle and fat tissues, and DJ634-GAL4 and PO163-GAL4 in the fat tissue. All logrank test p values were based on
comparison of the overexpressor strain with the driver alone. The plus symbol indicates the parental strain w1118. The mean lifespan at 29C
of the various genotypes were as follows. (A) gmr-GAL4/ UAS-dTsc2 (closed squares), 27 days (n  69); /gmr-GAL4 (open triangles), 31
days (n  102); /UAS-dTsc2 (open circles), 27 days (n  81) (p  0.01). (B) appl-GAL4/ UAS-dTsc2 (closed squares), 33 days (n  108);
/appl-GAL4 (open triangles), 32 days (n  85); /UAS-dTsc2 (open circles), 27 days (n  81) (p  0.001). (C) 24B- GAL4/UAS-dTsc2 (closed
squares), 37 days (n  107); /24B-GAL4 (open triangles), 31 days (n  67); /UAS-dTsc2 (open circles), 27 days (n  81) (p  0.0001). (D)
PO188-GAL4/UAS-dTsc2 (closed squares), 35 days (n  76); /PO188-GAL4 (open triangles), 24 days (n  71); / UAS-dTsc2 (open circles),
27 days (n  81) (p  0.0001). (E) DJ634-GAL4/UAS-dTsc2 (closed squares), 30.6 days (n  120); /DJ634-GAL4 (open triangles), 24.6 days
(n  120); /UAS-dTsc2 (open circles), 25.3 days (n  118) (p  0.0001). (F) PO163-GAL4/UAS-dTsc2 (closed squares), 36 days (n  126);
/PO163-GAL4 (open triangles), 28 days (n  87); /UAS-dTsc2 (open circles), 27 days (n  81) (p  0.0001). (G) DJ634-GAL4/UAS-dTORFRB
(closed squares), 31 days (n  107); /DJ634-GAL4 (open triangles), 25 days (n  120); /UAS-dTORFRB (open circles), 22 days (n  98) (p 
0.0001). (H) DJ634-GAL4/UAS-dS6kKQ (closed squares), 31 days (n  110); /DJ634-GAL4 (open triangles), 25 days (n  120); /UAS-dS6kKQ
(open circles), 23 days (n  115) (p  0.0001).
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implicated in regulating lifespan in conjunction with the
insulin pathway in Drosophila [4].
Supplemental Data
Supplemental data including a description of the Experimental
Procedures and two figures are available at http://www.current-
biology.com/cgi/content/full/14/10/885/DC1/.
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